MTAP expression also differs by breast cancer type: studies have shown that TNBC cells express significantly less MTAP than the more differentiated group made up of Luminal-A breast tumors, this would open the door for novel therapeutical strategies for the treatment of TNBC where endocrine or targeted therapy are usually ineffective [30]. The gene discussed is MTAP; the disease is breast carcinoma.